Iradimed Co (IRMD) — Cash Flow-to-Debt Ratio
Iradimed Co (IRMD) has a Cash Flow-to-Debt Ratio of 0.52x as of March 2026, meaning its operating cash flow of $8.29 Million could theoretically repay 1% of its total liabilities ($15.88 Million) in one year. Check cash flow reinvestment rate of Iradimed Co to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Iradimed Co Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Iradimed Co across 14 annual periods. Also explore balance sheet size of Iradimed Co for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Iradimed Co (2012–2025)
Year-by-year debt coverage analysis for Iradimed Co. For market capitalisation and broader financial context, see IRMD stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.76x | $24.95 Million | $14.16 Million | ▼ -20.9% |
| 2024 | 2.23x | $25.62 Million | $11.51 Million | ▲ +242.9% |
| 2023 | 0.65x | $13.47 Million | $20.74 Million | ▼ -23.4% |
| 2022 | 0.85x | $10.04 Million | $11.84 Million | ▼ -19.3% |
| 2021 | 1.05x | $11.26 Million | $10.71 Million | ▲ +75.0% |
| 2020 | 0.60x | $5.82 Million | $9.68 Million | ▼ -34.2% |
| 2019 | 0.91x | $10.23 Million | $11.20 Million | ▼ -19.6% |
| 2018 | 1.14x | $7.38 Million | $6.50 Million | ▲ +102.1% |
| 2017 | 0.56x | $3.42 Million | $6.08 Million | ▼ -68.3% |
| 2016 | 1.77x | $9.41 Million | $5.31 Million | ▼ -23.3% |
| 2015 | 2.31x | $7.65 Million | $3.31 Million | ▲ +116.1% |
| 2014 | 1.07x | $2.59 Million | $2.42 Million | ▲ +13.4% |
| 2013 | 0.94x | $1.47 Million | $1.56 Million | ▲ +45.8% |
| 2012 | 0.65x | $1.51 Million | $2.33 Million | — |